Lupus and IgA nephropathy: coexistence or coincident?
- PMID: 40105937
- PMCID: PMC12534307
- DOI: 10.1007/s00508-025-02512-y
Lupus and IgA nephropathy: coexistence or coincident?
Abstract
Background: Systemic lupus erythematosus is a multisystem autoimmune disease primarily manifesting as lupus nephritis. While lupus nephritis is the most common renal pathology in lupus, non-lupus nephropathies such as IgA nephropathy occasionally occur. This study aims to evaluate the clinical features and outcomes of lupus patients with IgA nephropathy, comparing them with those of primary IgA nephropathy and lupus nephritis.
Methods: A comprehensive literature review was conducted using the PubMed and Google Scholar databases to identify cases of systemic lupus erythematosus with IgA nephropathy reported between 1995 and December 2023. A total of 16 cases were identified and 2 additional cases from our clinic were included. These cases were compared with 47 lupus nephritis patients from our clinic and 215 primary IgA nephropathy patients from the literature. Data were collected on demographics, serology, renal biopsy findings, treatment, progression to renal failure and mortality.
Results: We identified 18 cases of lupus with IgA nephropathy with a median age of 41.6 years and a female predominance (72.2%). In comparison to the primary IgA nephropathy cohort, lupus with IgA nephropathy group exhibited a lower rate of renal failure (11.1% vs. 34%) and mortality (5.6% vs. 20%). Additionally, the lupus-IgA nephropathy group showed a slightly lower mortality rate compared to the lupus nephritis cohort (5.6% vs. 10.6%).
Conclusion: Lupus with predominantly IgA deposits often follows a more indolent course than primary IgA nephropathy but severe cases with crescentic glomerulonephritis can still progress to renal failure.
Keywords: IgA nephropathy; Kidney failure; Lupus nephritis; Prognosis; Systemic lupus erythematosus.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Conflict of interest: R. Duran, D. Yıldırım, R. Can Kardaş, İ. Vasi, B. Kaya, Y. Çakır, İ. Karaduman, H. Küçük, B. Göker, M.A. Öztürk and A. Erden declare that they have no competing interests. Ethical standards: This study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants prior to their inclusion in the study.
References
-
- Baranowska-Daca E, Choi YJ, Barrios R, Nassar G, Suki WN, Truong LD. Nonlupus nephritides in patients with systemic lupus erythematosus: a comprehensive clinicopathologic study and review of the literature. Hum Pathol. 2001;32(10):1125–35. 10.1053/hupa.2001.28227. - PubMed
-
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–7. 10.1002/art.1780251101. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous